azd3043
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00918515)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Gamma-amino-N-butyrate transaminaseACTIVATOR
ABAT activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd3043
- azd3043
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01086813 | Phase 1 | Mar 1, 2010 | AstraZeneca, IQVIA |
| NCT01028040 | Phase 1 | Dec 1, 2009 | AstraZeneca, Richmond Pharmacology |
| NCT00984880 | Phase 1 | Sep 1, 2009 | AstraZeneca, Karolinska Institute |
| NCT00918515 | Phase 1 | May 1, 2009 | AstraZeneca, Karolinska Institute |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 4 | 4 | 1 | 2009 |
| Karolinska Institute | Academic/Hospital | 2 | 0 | 1 | 2009 |
| IQVIA | For profit | 1 | 0 | 1 | 2010 |
| Richmond Pharmacology | For profit | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1